ABBV STOCK HITS RECORD ALL TIME HIGH

Quote




not exactly sure what your looking for. Abbvie is ready to gain back from the loses they have suffered in the last few months. the fact is that the share price didn't deserve to be hammered the way it was. a 10% drop would have been understandable.....the reality is that this is a biotech stock and will be more volatile than most stocks...while painful at times it will reap huge rewards in the next few years....after that it might be a different story but who cares, I will be long out of it by then.
 








anonymous said:
not exactly sure what your looking for. Abbvie is ready to gain back from the loses they have suffered in the last few months. the fact is that the share price didn't deserve to be hammered the way it was. a 10% drop would have been understandable.....the reality is that this is a biotech stock and will be more volatile than most stocks...while painful at times it will reap huge rewards in the next few years....after that it might be a different story but who cares, I will be long out of it by then.
Click to expand...

Disagree, It should have tanked even more and it will be steadily heading south as Investors figure out the serious flaws this company has. The Street knows more than you do. Its nice to have wishful thinking if you work here so your 401k grows with ABBV stock.
 




anonymous said:
Disagree, It should have tanked even more and it will be steadily heading south as Investors figure out the serious flaws this company has. The Street knows more than you do. Its nice to have wishful thinking if you work here so your 401k grows with ABBV stock.
Click to expand...
LMAO !!! You can't be serious ! ABBV is about to take off and will be $150 by Q4 this year, if not higher. And my FINRA licensed financial guru believes strongly in our company. Yes they know more about ABBV than you. And I have most of my 401k in ABBV as I believe in our tremendous pipeline.

So stop promulgating your line of BS !!
 




anonymous said:
Disagree, It should have tanked even more and it will be steadily heading south as Investors figure out the serious flaws this company has. The Street knows more than you do. Its nice to have wishful thinking if you work here so your 401k grows with ABBV stock.
Click to expand...

MYL is partnering with Fujifilm Kyowa Kirin Biologics Co., Ltd. to commercialize a biosimilar to ABBV's Humira.

ABBV is a one-trick pony. 59% of its revenue is derived from Humira.

MYL has been approved for a biosimilar before. It won FDA approval for TEVA's Copaxone and is poised to win a patent suit against AGN.

Any hit to Humira could wreck ABBV. Sell ABBV.
 




anonymous said:
MYL is partnering with Fujifilm Kyowa Kirin Biologics Co., Ltd. to commercialize a biosimilar to ABBV's Humira.

ABBV is a one-trick pony. 59% of its revenue is derived from Humira.

MYL has been approved for a biosimilar before. It won FDA approval for TEVA's Copaxone and is poised to win a patent suit against AGN.

Any hit to Humira could wreck ABBV. Sell ABBV.
Click to expand...

Fake news like the above is rampant here on CP. NOTHING will replace Humira . It is the GOLD STANDARD. Buy ABBV .
 




anonymous said:
MYL is partnering with Fujifilm Kyowa Kirin Biologics Co., Ltd. to commercialize a biosimilar to ABBV's Humira.

ABBV is a one-trick pony. 59% of its revenue is derived from Humira.

MYL has been approved for a biosimilar before. It won FDA approval for TEVA's Copaxone and is poised to win a patent suit against AGN.

Any hit to Humira could wreck ABBV. Sell ABBV.
Click to expand...

We are doomed !!!!!!!!
 




anonymous said:
The share buy back of $7.5 billion is a smoke screen to boost crumbling stock. The Corporate Tax reform was not meant to let greedy CEOs like Rick to pull this BS move. Trump was an idiot giving these leechs a licence to steal.
Click to expand...


So Rick sold his soul for (5.48%) Stock increase ? When the house of cards comes tumbling dow ABBV will be @ $60.

May 1, 2018 9:01 AM ET|About: AbbVie Inc. (ABBV)|By: Douglas W. House, SA News Editor


AbbVie (NYSE:ABBV) is up 5% premarket on increased volume on the heels of its announcement that it has launched a cash tender offer for up to $7.5B of its common stock at prices between $99 and 114 per share.

The offer expires on May 29 unless extended.
AbbVie Inc
NYSE: ABBV
101.84 USD +5.29 (5.48%)
 








anonymous said:
Just placed buy order for 750 shares, max 90. This may be the bargain of the year if I get it. This stock will be pushing 125 to 150 by 3Q18 per financial pro's in pharma. Cant believe more aren't doing this. You must be dumb as a brick to not buy in. Wish I had more cash to put in, but wife needs a new car.
Click to expand...

Just riding the wave folks... should have taken my advice.

ABBV up 5.52 today
sitting at 102.07 and rising!
 




anonymous said:
So Rick sold his soul for (5.48%) Stock increase ? When the house of cards comes tumbling dow ABBV will be @ $60.

May 1, 2018 9:01 AM ET|About: AbbVie Inc. (ABBV)|By: Douglas W. House, SA News Editor


AbbVie (NYSE:ABBV) is up 5% premarket on increased volume on the heels of its announcement that it has launched a cash tender offer for up to $7.5B of its common stock at prices between $99 and 114 per share.

The offer expires on May 29 unless extended.
AbbVie Inc
NYSE: ABBV
101.84 USD +5.29 (5.48%)
Click to expand...

Stocks ready to tank !
 




anonymous said:
So Rick sold his soul for (5.48%) Stock increase ? When the house of cards comes tumbling dow ABBV will be @ $60.

May 1, 2018 9:01 AM ET|About: AbbVie Inc. (ABBV)|By: Douglas W. House, SA News Editor


AbbVie (NYSE:ABBV) is up 5% premarket on increased volume on the heels of its announcement that it has launched a cash tender offer for up to $7.5B of its common stock at prices between $99 and 114 per share.

The offer expires on May 29 unless extended.
AbbVie Inc
NYSE: ABBV
101.84 USD +5.29 (5.48%)
Click to expand...

This modified accelerated buy back using the Dutch tender offer model is a desperate attempt by AbbVie to save face. There's skeletons in AbbVies closet that will come out to haunt this company. Looking for 30% drop.
 




anonymous said:
Just riding the wave folks... should have taken my advice.

ABBV up 5.52 today
sitting at 102.07 and rising!
Click to expand...
Great move. My financial advisor has been preaching to me that ABBV is going to hit 150 this year since last Dec. I bought a bunch at 90-92 and wish I got more. The idiots here about it dropping simply do not understand how the market works. Their loss.
 




















anonymous said:
This modified accelerated buy back using the Dutch tender offer model is a desperate attempt by AbbVie to save face. There's skeletons in AbbVies closet that will come out to haunt this company. Looking for 30% drop.
Click to expand...


Not a good sign. Games OVER Rick !

Dow Jones Industrial Average
INDEXDJX: .DJI -- UP +332.63 (1.39%)

AbbVie Inc
NYSE: ABBV
$100.17 USD -- DOWN −0.095 (0.095%)



 




Besides pipeline tanking and impending Humira loss, the fact that AbbVie has 69.34 billion in total assets, offset by 65.79 billion in total liabilities is a recipe for disaster.

AbbVie Inc
NYSE: ABBV
$99.75 USD Down−0.42 (0.42%)
 




Top Bottom
Back
Quote